今天
-3.30%
5天
-1.12%
1月
+8.64%
6月
-8.65%
今年開始到現在
+46.67%
1年
+51.72%
Protalix BioTherapeutics (PLX) 2026 年第 2 季財報電話會議:Elfabrio 帶動營收成長


| 持股股東 | 佔比 |
|---|---|
| MAK Capital One, LLC | 4.49% |
| BlackRock Institutional Trust Company, N.A. | 4.06% |
| Bashan (Dror) | 3.14% |
| Opaleye Management Inc. | 3.08% |
| 股東類型 | 佔比 |
|---|---|
| Hedge Fund | 9.63% |
| Investment Advisor | 9.41% |
| Investment Advisor/Hedge Fund | 4.05% |
| Individual Investor | 3.88% |
相關品種